A 3-month clofazimine-rifapentine-containing regimen for drug-susceptible tuberculosis versus standard of care (Clo-Fast): a randomised, open-label, phase 2c clinical trial. (linkinghub.elsevier.com)

Authors: Metcalfe JZ … Chaisson R Journal: Lancet Infectious Diseases Published: 2026-01-01 DOI: https://doi.org/10.1016/S1473-3099(25)00436-0